Wildcat Capital Management, LLC Kronos Bio, Inc. Call Options Transaction History
Wildcat Capital Management, LLC
- $152 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KRON
# of Institutions
5Shares Held
889KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY874KShares$769,2090.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ12KShares$10,5890.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.66KShares$1,4630.0% of portfolio
-
Dakota Community Bank & Trust Na Hebron, ND943Shares$8290.0% of portfolio
-
Jpmorgan Chase & CO New York, NY441Shares$3880.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $50M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...